Back to search

University of Crete (UOC)

Μοριακός μηχανισμός απευαισθητοποίησης μελανοκυττάρων στην κυτταροστατική δράση του αυξητικού παράγοντα μετασχηματισμού β (Transforming Growth Factor β, TGF-β) κατά την καρκινογένεση: στόχος φαρμακολογικής παρέμβασης στη θεραπεία του μελανώματος

Abstract

dc:description

Carcinogenesis is likely to result from the production of autocrine growth factors, as well as from loss of response to polypeptide growth inhibitors. TGF-β inhibits the proliferation of normal cells, whereas the loss of its cytostatic action during carcinogenesis can occur either through gene mutations or absence of TGF-β receptors, or perturbation of the Smad signaling pathway. Cancer cells that have lost TGF-β responses become more aggressive. The TGF-β acts as a ligand, which assembles membrane receptor complexes that subsequently activate Smad proteins, which form transcriptional complexes that control gene expression. Smad proteins interact with various cofactors that bind to DNA, and form complexes with specific target genes. In malignant melanoma, the mechanism that leads to the repression of the antiproliferative effect of TGF-β remains largely unknown. The tumor promoting phorbol esters act mainly on protein kinase C (PKC), an enzyme that participates in melanocyte signal transduction and is involved in the process of melanocyte carcinogenesis. In the present investigation, we observed the complete abolishment of the cytostatic action of TGF-β in melanocytes and melanoma cells after exposure to 12-O-tetradecanoylphorbol-13-acetate (TPA), a tumor promoting phorbol ester. This was associated with downregulation of several PKC isoforms. Also, Smad-dependent transcriptional activity was suppressed in TPA-treated melanocytes. Using specialized PKC inhibitors and a PKCα antisense oligonucleotide, we concluded that the PKCα isoenzyme is an important component of the TGF-β/Smad signaling pathway in melanocytes. PKCα, using suitable enzyme modifiers, may become a target for therapeutic intervention in melanoma.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Σταυρουλάκη, Μελανθία
  • Stavroulaki, Melanthia

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/16272

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Σταυρουλάκη, Μελανθία; Stavroulaki, Melanthia. Μοριακός μηχανισμός απευαισθητοποίησης μελανοκυττάρων στην κυτταροστατική δράση του αυξητικού παράγοντα μετασχηματισμού β (Transforming Growth Factor β, TGF-β) κατά την καρκινογένεση: στόχος φαρμακολογικής παρέμβασης στη θεραπεία του μελανώματος. University of Crete (UOC), 2007. http://hdl.handle.net/10442/hedi/16272